Comparing the safety and efficacy of sodium valproate, levetiracetam, and phenytoin in attenuating the severity of agitation in patients with post-traumatic brain injury: An observational study
PLOS One · 03.06.2026 · 21 (6) · e0350585
DOI: 10.1371/journal.pone.0350585 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 03.06.2026. Verfasst von Shivani Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India. Hauptthemen laut MEDLINE: Phenytoin, Valproic Acid, Brain Injuries, Traumatic, Anticonvulsants. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The present study aimed to compare the safety and efficacy of sodium valproate, levetiracetam, and phenytoin in agitation control. Methods and Material This prospective observational study included 189 adult patients with traumatic brain injury (TBI) receiving sodium valproate, phenytoin, and levetiracetam. Agitation was monitored using the Richmond Agitation-Sedation Scale (RASS) at baseline and serially over seven days. The study evaluated the percentage of patients who experienced agitation-relief (A-R) following antiepileptic drugs, along with pattern of adverse events among the three groups.
Results
Sodium valproate (sod.v) demonstrated better efficacy with 85.7% of patients achieving A-R compared to 63.5% in levetiracetam (P = 0.016). The median time to achieve A-R was 3 days in sod.v and significantly lesser compared to 4 days in phenytoin (P = 0.04) and 5 days in levetiracetam (P = 0.0001). By day 4, 72% of patients in the sod.v achieved A-R, in contrast to 50% in the phenytoin and 31.7% in the levetiracetam group. The safety profile of sod.v and levetiracetam was more favorable with lesser occurrence of adverse events compared to phenytoin (P = 0.017).
Conclusions
To our knowledge, this is the first pivotal evidence to compare antiepileptics for agitation control in post-traumatic brain injury patients. Our study demonstrated that patients receiving sodium valproate showed relatively greater and earlier improvement in agitation control, with an acceptable safety profile. The study proves the dual benefits of sod.v in post-TBI improving patient outcomes and alleviating mental strain on patients, and their families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Neurosurgery, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, IIndia.
- Department of Applied Statistics and Data Science, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, IIndia.
ORCID-Profile: Shivaprakash Gangachannaiah, Varun Kumar S G
Zitieren
APA
Singh, S., Nayak, R., Gangachannaiah, S., Bhosale, A., Parveen, R. S., Kumar S G, V., & Sundar, G. (2026). Comparing the safety and efficacy of sodium valproate, levetiracetam, and phenytoin in attenuating the severity of agitation in patients with post-traumatic brain injury: An observational study. PLOS One, 21(6), e0350585. https://doi.org/10.1371/journal.pone.0350585
Vancouver
Singh S, Nayak R, Gangachannaiah S, Bhosale A, Parveen RS, Kumar S G V, et al. Comparing the safety and efficacy of sodium valproate, levetiracetam, and phenytoin in attenuating the severity of agitation in patients with post-traumatic brain injury: An observational study. PLOS One. 2026;21(6):e0350585. doi:10.1371/journal.pone.0350585
BibTeX
@article{Singh2026,
author = {Singh, Shivani and Nayak, Raghavendra and Gangachannaiah, Shivaprakash and Bhosale, Ashutosh and Parveen, Reena Sherin and Kumar S G, Varun and Sundar, Geeta},
title = {Comparing the safety and efficacy of sodium valproate, levetiracetam, and phenytoin in attenuating the severity of agitation in patients with post-traumatic brain injury: An observational study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0350585},
doi = {10.1371/journal.pone.0350585}
}
EUVIMED